Filing Details
- Accession Number:
- 0001567619-23-003317
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-02-17 17:12:31
- Reporting Period:
- 2023-02-15
- Accepted Time:
- 2023-02-17 17:12:31
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1528115 | Annexon Inc. | ANNX | Pharmaceutical Preparations (2834) | 275414423 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1818520 | Douglas Love | C/O Annexon, Inc. 1400 Sierra Pt Pkwy, Bldg C, 2Nd Floor Brisbane CA 94005 | President & Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2023-02-15 | 6,571 | $5.87 | 197,646 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units.
- This transaction was executed in multiple trades in prices ranging from $5.80 to $5.95, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
- Includes 3,274 shares acquired on May 15, 2022 and 1 share acquired on November 15, 2022, pursuant to the Issuer's Employee Stock Purchase Plan.
- Includes 26,667 restricted stock units.
Billionaire Hedge Funds
